Found 6 matching trials
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
PHASE2This is an open label controlled household-randomised trial designed to eva...
Location
Imperial College Healthcare NHS Trust
Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis
PHASE2A Phase 2, Single-Centre, Open-Label, Parallel Control Arm, Randomised Clin...
Location
TASK Clinical Research Centre
A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19
PHASE2The effect of RESP301 as an add on treatment to SOC will be evaluated for i...
Location
Imperial College Healthcare NHS Trust, St. Mary's Hospital
Study of a Nebulised Nitric Oxide Generating Solution in Patients With Mycobacterium Abscessus
PHASE2* To evaluate the change in M. abscessus cfu/g in induced sputum samples fr...
Location
Royal Papworth Hospital NHS Foundation Trust
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
PHASE2Patients with a respiratory disease are at higher risk of poor outcomes due...
Location
Medicines Evaluation Unit
Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
PHASE3The aim of this study is to reduce pulmonary complications in adult patient...
Location
University Of Abuja Teaching Hospital (Spoke)